CoChat

Modulation of LMNA splicing as a strategy to treat prelamin A diseases

Open access
Lee, John M., Nobumori, Chika, Tu, Yiping, Choi, Catherine, Yang, Shao H., Jung, Hea-Jin, Vickers, Timothy A., Rigo, Frank, Bennett, C. Frank, Young, Stephen G., Fong, Loren G. · 2016 · Journal of Clinical Investigation
Cited by 111

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The alternatively spliced products of LMNA, lamin C and prelamin A (the precursor to lamin A), are produced in similar amounts in most tissues and have largely redundant functions. This redundancy suggests that diseases, such as Hutchinson-Gilford progeria syndrome (HGPS), that are caused by prelamin A-specific mutations could be treated by shifting the output of LMNA more toward lamin C. Here, we investigated mechanisms that regulate LMNA mRNA alternative splicing and assessed the feasibility of reducing prelamin A expression in vivo. We identified an exon 11 antisense oligonucleotide (ASO) that increased lamin C production at the expense of prelamin A when transfected into mouse and human fibroblasts. The same ASO also reduced the expression of progerin, the mutant prelamin A protein in HGPS, in fibroblasts derived from patients with HGPS. Mechanistic studies revealed that the exon 11 sequences contain binding sites for serine/arginine-rich splicing factor 2 (SRSF2), and SRSF2 knockdown lowered lamin A production in cells and in murine tissues. Moreover, administration of the exon 11 ASO reduced lamin A expression in wild-type mice and progerin expression in an HGPS mouse model. Together, these studies identify ASO-mediated reduction of prelamin A as a potential strategy to treat prelamin A-specific diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci85908

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 111

Metadata

Authors
Lee, J. M., Nobumori, C., Tu, Y., Choi, C., Yang, S. H., Jung, H.-J., Vickers, T. A., Rigo, F., Bennett, C. F., Young, S. G., & Fong, L. G.
Venue
Journal of Clinical Investigation
Published
2016-03-21
Volume
126
Issue
4
Pages
1592-1602
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2311161794
Cited by
111
References
1
FWCI
5.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulation of LMNA splicing as a strategy to treat prelamin A diseases. https://app.cochat.ai/papers/10.1172/jci85908
The paper
Lee, J. M., Nobumori, C., Tu, Y., Choi, C., Yang, S. H., Jung, H.-J., Vickers, T. A., Rigo, F., Bennett, C. F., Young, S. G., & Fong, L. G. (2016). Modulation of LMNA splicing as a strategy to treat prelamin A diseases. Journal of Clinical Investigation. https://doi.org/10.1172/jci85908

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.